| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5815086 | Neuropharmacology | 2013 | 10 Pages |
Abstract
⺠The post-TBI levels of sAPPα were restored by etazolate treatment. ⺠Etazolate decreases IL-1β levels, cerebral oedema and microglial activation. ⺠Locomotor hyperactivity and memory deficit were attenuated by etazolate treatment. ⺠Etazolate protects olfactory bulb tissue in a persistent manner. ⺠The therapeutic window of etazolate is at least 2 h.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Eleni Siopi, Gemma Llufriu-Dabén, Angelo H. Cho, Sandra Vidal-Lletjós, Michel Plotkine, Catherine Marchand-Leroux, Mehrnaz Jafarian-Tehrani,